Navigation Links
Reportlinker Adds Monoclonal Antibodies: 2010
Date:12/8/2010

010 132

Table 23: Count of Phase III-registration MAb players, 2010 134

Table 24: Count of companies with multiple Phase I–II mAb candidates, 2010 137

Table 25: MAb count split by technology type, 2010 141

Table 26: MAb count split by therapy area, 2010 145

Table 27: Detailed product/target analysis of MAbs in late-stage development, 2010 148

Table 28: Novel late-stage MAb targets, 2010 150

Table 29: Novel early-stage MAb targets, 2010 151

Table 30: MAb market key products overview 157

Table 31: Avastin: overview 158

Table 32: Avastin: sales forecast ($m), 2009–15 159

Table 33: MabThera/Rituxan: overview 160

Table 34: MabThera/Rituxan: sales forecast ($m), 2009–15 161

Table 35: Herceptin: overview 162

Table 36: Herceptin: sales forecast ($m), 2009–15 163

Table 37: Erbitux: overview 164

Table 38: Erbitux: sales forecast ($m), 2009–15 165

Table 39: Prolia (oncology): overview 166

Table 40: Prolia (onco): sales forecast ($m), 2009–15 167

Table 41: Vectibix: overview 168

Table 42: Vectibix : sales forecast ($m), 2009–15 169

Table 43: Arzerra: overview 170

Table 44: Humira: overview 171

Table 45: Humira: sales forecast ($m), 2009–15 172

Table 46: Remicade: overview 173

Table 47: Remicade: sales forecast ($m), 2009–15 174

Table 48: Simponi: overview 175

Table 49: Simponi: sales forecast ($m), 2009–15 176

Table 50: Actemra: overview 177

Table 51: Actemra: sales forecast ($m), 2009–15 178

Table 52: Benlysta: overview 179

Table 53: Benlysta: sales forecast ($m), 2009–15 180

Table 54: Stelara: overview 181

Table 55: Stelara: sales forecast ($m), 2009–15 182

Table 56: Tysabri: overview 183

Table 57: Tysabri: sales forecast ($m), 2009–15 184

Table
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
(Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical Inc. ... company that specializes in the patented biopharmaceutical, modernized traditional ... (API), provided updates regarding the notice it received on ... "Exchange") indicating that the Company was below certain of ... Sections 134 and 1101 of the NYSE MKT Company ...
(Date:7/30/2015)... 30, 2015 Future Market Insights ... "Continuous Glucose Monitoring Systems Market: Global Industry Analysis and ... the global continuous glucose monitoring systems market was valued ... to reach US$ 788.4 Mn by 2020, registering a ... 2020. Global continuous glucose monitoring systems market ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
(Date:7/30/2015)... ... 30, 2015 , ... The Clinical Data Interchange Standards Consortium ... announce that data standards for clinical research in the areas of Schizophrenia, Hepatitis ... . These three Therapeutic Area (TA) standards were developed per the CDISC global, ...
(Date:7/30/2015)... ... July 30, 2015 , ... In an effort to provide ... Aggarwal is making a change in his practice. , The decision will also allow ... 2015, Dr. Aggarwal will be transferring his in-patient admissions to the hospitalists at East ...
(Date:7/30/2015)... FL (PRWEB) , ... July 30, 2015 , ... ... new online program entitled " Lovetraction Lines ." It's for women interested in ... the men they desire. The course, which officially launched to the public early ...
(Date:7/30/2015)... ... 30, 2015 , ... In a meaningful ritual intended to symbolize a final ... Center have created an addiction graveyard. Sharing this with the public comes at a ... Rocky Hudson . Hudson (1945-2015) fell in love with the desert when he moved ...
(Date:7/30/2015)... MD (PRWEB) , ... July 30, 2015 , ... ... serving the Mid-Atlantic region, is the recipient of three awards in the Service ... for communications programs created for Choptank Transport, KRM Development Corporation and University of ...
Breaking Medicine News(10 mins):Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Lovetraction Lines - Review Examining Simone Myers' New Online Course Released 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 3Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 2Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 3
... Oct. 14 The 2009 Cumulative Supplement ... the latest legal developments in pharmaceutical patent law. Published by ... BNA , Pharmaceutical Patent Law is ... the antitrust implications of patent settlements; the experimental use privilege; ...
... Wash., Oct. 14 Spectrum Pension Consultants, a retirement plan ... that the 2009 Spectrum Open raised over $100,000, including enough ... at St. Joseph,s Hospital. , "This event was a huge ... and fundraising perspective. It was incredible to watch pledges come ...
... Southern Company (NYSE: SO ), announced today the ... Heroes: Barfield, Murphy, Shank & Smith of Birmingham, Ala., ... Pizza of Pensacola, Fla. , (Logo: ... created the 2009 Southern Heroes promotion to recognize ...
... , Delays contribute to unnecessary ER visits and additional ... patients to the operating room more quickly could cut by ... researchers reported today at the 2009 Clinical Congress of the ... patients who underwent surgical treatment for gallstones at the University ...
... medical interventions are ordered for these end-stage patients, researchers ... people see end-stage dementia as affecting only the mind, ... are far-reaching and eventually fatal. , The misconception ... a terminal condition can have negative consequences for ...
... ... preferred provider organization (PPO) plans in Albany, Essex, Rensselaer, Saratoga, Schenectady, Schoharie, Warren, and ... counties, CDPHP Medicare Choices individual PPO plans now serve Medicare-eligibles in 23 counties, while ... ...
Cached Medicine News:Health News:New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 2Health News:New 2009 Cumulative Supplement to Pharmaceutical Patent Law Examines Critical Intersection Of Patent Law and Food And Drug Law 3Health News:4th Annual Spectrum Open: A Big Success 2Health News:SouthernLINC Wireless Selects 2009 Southern Heroes 2Health News:SouthernLINC Wireless Selects 2009 Southern Heroes 3Health News:SouthernLINC Wireless Selects 2009 Southern Heroes 4Health News:Quicker Referral for Gallbladder Operation Could Save 50 Percent of Preoperative Treatment Charges 2Health News:Quicker Referral for Gallbladder Operation Could Save 50 Percent of Preoperative Treatment Charges 3Health News:Families Need to Know When Dementia Becomes Terminal 2Health News:Families Need to Know When Dementia Becomes Terminal 3Health News:CDPHP Launches Individual Medicare Choices PPO Plan in the Capital Region 2Health News:CDPHP Launches Individual Medicare Choices PPO Plan in the Capital Region 3Health News:CDPHP Launches Individual Medicare Choices PPO Plan in the Capital Region 4
... System is the next generation ... the symptoms of BPH. This ... the prostate while dilating the ... well tolerated by patients and ...
... proud to announce the release of the OES ... optics with our most commonly used cystoscopy sheaths ... level. Now you can have one instrument that ... the OES Pro cystoscopes offer a superior channel ...
... Defibrillator is a simple "1, 2, ... is compact with a streamline design ... only 13.5 lbs. It rapidly charges ... has full summary pre- & post-event ...
Incontinence Pessaries...
Medicine Products: